581 related articles for article (PubMed ID: 25517440)
1. [New challenges and perspectives in nuclear medicine imaging].
Borbély K
Magy Onkol; 2014 Dec; 58(4):232-8. PubMed ID: 25517440
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
3. [New trends and novel possibilities in the management of oncologic patients: clinical uses of PET/MRI].
Borbély K
Magy Onkol; 2015 Mar; 59(1):10-6. PubMed ID: 25763908
[TBL] [Abstract][Full Text] [Related]
4. Hybrid SPECT/CT imaging in neurology.
Ciarmiello A; Giovannini E; Meniconi M; Cuccurullo V; Gaeta MC
Curr Radiopharm; 2014; 7(1):5-11. PubMed ID: 25143053
[TBL] [Abstract][Full Text] [Related]
5. [Hybrid imaging: clinical evidence, opportunities].
Trencsényi G; Barna SK; Garai I
Orv Hetil; 2015 Dec; 156(52):2110-5. PubMed ID: 26686747
[TBL] [Abstract][Full Text] [Related]
6. Technological advances in hybrid imaging and impact on dose.
Mattsson S; Andersson M; Söderberg M
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):410-5. PubMed ID: 25802466
[TBL] [Abstract][Full Text] [Related]
7. [Why is PET/CT essential in urooncology?].
Borbély K; Géczi L; Kásler M
Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
[TBL] [Abstract][Full Text] [Related]
8. Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.
Sathekge M; Maes A; D'Asseler Y; Vorster M; Van de Wiele C
Nucl Med Commun; 2012 Jun; 33(6):581-90. PubMed ID: 22422098
[TBL] [Abstract][Full Text] [Related]
9. Future Challenges of Multimodality Imaging.
López-Mora DA; Lagos LA; Estorch M; Carrio I
Recent Results Cancer Res; 2020; 216():905-918. PubMed ID: 32594412
[TBL] [Abstract][Full Text] [Related]
10. Radiation dose in nuclear medicine: the hybrid imaging.
Salvatori M; Rizzo A; Rovera G; Indovina L; Schillaci O
Radiol Med; 2019 Aug; 124(8):768-776. PubMed ID: 30771217
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
[TBL] [Abstract][Full Text] [Related]
12. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
13. Nuclear medicine examinations of children in Russia.
Zvonova I; Chipiga L; Balonov M; Ermolina E
Radiat Prot Dosimetry; 2015 Jul; 165(1-4):216-9. PubMed ID: 25836687
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls and Limitations of Radionuclide and Hybrid Imaging in Infection and Inflammation.
Glaudemans AW; Israel O; Slart RH
Semin Nucl Med; 2015 Nov; 45(6):500-12. PubMed ID: 26522392
[TBL] [Abstract][Full Text] [Related]
15. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
16. Hybrid PET/MR imaging: physics and technical considerations.
Shah SN; Huang SS
Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
[TBL] [Abstract][Full Text] [Related]
17. [New trends and novel possibilities in the clinical use of SPECT/CT imaging].
Zámbó K; Schmidt E; Szabó Z; Sarkadi M; Dérczy K; Szekeres S
Magy Onkol; 2015 Mar; 59(1):17-24. PubMed ID: 25763909
[TBL] [Abstract][Full Text] [Related]
18. Variability of target and normal structure delineation using multimodality imaging for radiation therapy of pancreatic cancer.
Dalah E; Moraru I; Paulson E; Erickson B; Li XA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(3):633-40. PubMed ID: 24755533
[TBL] [Abstract][Full Text] [Related]
19. Combined imaging modalities: PET/CT and SPECT/CT.
Maurer AH
Health Phys; 2008 Nov; 95(5):571-6. PubMed ID: 18849691
[TBL] [Abstract][Full Text] [Related]
20. Overview of positron emission tomography, hybrid positron emission tomography instrumentation, and positron emission tomography quantification.
Kwee TC; Torigian DA; Alavi A
J Thorac Imaging; 2013 Jan; 28(1):4-10. PubMed ID: 23249967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
